People living with HIV in South Africa, who access antiretroviral therapy (ART) before their immune systems are severely compromised, have life expectancies close to that of the general population, researchers have found.
Published this week in the journal PLOS Medicine, the research shows that the life expectancies (additional years of life) are around 80% of that of the general population, provided those with HIV initiate treatment before their CD4 count (a measure of the strength of the immune system at the time of starting treatment) drops below 200.
...
AllAfrica Subscription Content
You must be an allAfrica.com subscriber for full access to certain content.
You have selected an article from the AllAfrica archive, which requires a subscription. You can subscribe by visiting our subscription page. Or for more information about becoming a subscriber, you can read our subscription and contribution overview.
For information about our premium subscription services:
You can also freely access - without a subscription - hundreds of today's top Africa stories and thousands of recent news articles from our home page »
Already a subscriber? Sign in for full access to article